A new study has claimed that the lack of growth hormone activity could protect very short people from diseases such as cancer and diabetes . The research, published in Science Translational Medicine, examined people from remote villages in the Andes mountains in Ecuador over a period of 22 years.
The team focused on community members who suffer from Laron syndromen, a gene mutation that prevents the body from using growth hormone, which is especially prevalent in these villages. Those with Laron’s were found to have very low insulin levels and low insulin resistance, which could be why there was an absence of diabetes .
Valter Longo, of the University of Southern California, commented “The growth hormone receptor-deficient people don’t get two of the major diseases of aging. They also have a very low incidence of stroke, but the number of deaths from stroke is too small to determine whether it’s significant.”
It was claimed that if high growth factor levels do become a risk factor for cancer in the same way that cholesterol is a risk factor for cardiovascular diseases, then treatments that reduce the growth factor could become the new statins .
It was also shown that serum from the villagers with Laron syndrome helped protect DNA against oxidative damage and mutations and also promoted the suicide of cells that became highly damaged.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…